Piktor (PI3K/mTOR Inhibitor)
Phase 2Advanced Endometrial Cancer
Stock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| Piktor (PI3K/mTOR Inhibitor) | Advanced Endometrial Cancer | Phase 2 | Dec 31, 2026 | — |
| Piktor (PI3K/mTOR Inhibitor) | HR+/HER2- Advanced Breast Cancer | Phase 1/2 | Dec 31, 2027 | — |
Upcoming milestones
Advanced Endometrial Cancer
Company profile
Sensei Biotherapeutics is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
HR+/HER2- Advanced Breast Cancer
Data readout